Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 21.60% institutional investors, 0.45% insiders, and 77.95% retail investors. Vanguard group is the largest institutional shareholder, holding 9.08% of IOVA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 21.60% | 0.45% | 77.95% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 27.53M | 9.08% | $203.75M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| Blackrock funding, inc. /de | 23.48M | 7.74% | $173.72M |
| Mhr fund management | 24.42M | 7.56% | $81.31M |
| State street | 12.63M | 4.74% | $101.25M |
| Perceptive advisors | 12.71M | 3.94% | $42.33M |
| Hood river capital management | 9.22M | 2.85% | $30.69M |
| Soleus capital management | 7.79M | 2.41% | $25.92M |
| Geode capital management | 5.87M | 1.94% | $43.46M |
| T. rowe price investment management | 5.83M | 1.92% | $43.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mhr fund management | 24.42M | 9.77% | $81.31M |
| Orion investment | 1.06M | 3.13% | $7.85M |
| Parametrica management | 261.09K | 2.55% | $1.93M |
| Apis capital advisors | 1.28M | 2.06% | $4.25M |
| Palo alto investors lp | 3.21M | 2.04% | $10.69M |
| Cm management | 300.00K | 1.98% | $2.22M |
| Soleus capital management | 7.79M | 1.87% | $25.92M |
| Bioimpact capital | 2.71M | 1.55% | $9.02M |
| Perceptive advisors | 12.71M | 1.49% | $42.33M |
| Long focus capital management | 5.13M | 1.23% | $37.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Invenomic capital management lp | 5.49M | 0.92% | 5.49M |
| Man group | 2.41M | 0.05% | 2.41M |
| State street | 12.63M | 0.00% | 2.22M |
| Ubs group | 2.70M | 0.00% | 2.08M |
| Blackrock funding, inc. /de | 23.48M | 0.00% | 1.99M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | 12.71M | 1.49% | -9.40M |
| Avoro capital advisors | - | - | -3.50M |
| Balyasny asset management | 2.82M | 0.03% | -1.65M |
| Summit partners public asset management | - | - | -1.56M |
| Siren | - | - | -1.11M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Invenomic capital management lp | 5.49M | 0.92% | 5.49M | $18.28M |
| Man group | 2.41M | 0.05% | 2.41M | $17.87M |
| Assenagon asset management | 1.75M | 0.02% | 1.75M | $12.93M |
| Raymond james financial | 1.56M | 0.00% | 1.56M | $11.57M |
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -4.00 |
| Sjs investment consulting | -4.00 |
| Capital performance advisors llp | -11.00 |
| Massmutual trust co fsb/adv | -28.00 |
| Cibc private wealth group | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 24 | -92.48% | 69,746,593 | -71.12% | 21 | 0.34% | 12 | -92.36% | 4 | -95.40% |
| Dec 31, 2024 | 193 | -35.02% | 100,034,590 | -57.33% | 32 | 0.55% | 92 | -39.07% | 50 | -37.50% |
| Sep 30, 2024 | 292 | -5.19% | 234,393,808 | 0.82% | 77 | 1.01% | 149 | -17.22% | 80 | -2.44% |
| Jun 30, 2024 | 305 | 2.69% | 232,471,450 | 7.59% | 87 | 1.23% | 177 | 9.94% | 82 | -6.82% |
| Mar 31, 2024 | 297 | 18.33% | 216,063,214 | 4.25% | 84 | 1.19% | 161 | 13.38% | 88 | 31.34% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 8.90M | 2.67% | 250.00K |
| Vanguard US Total Market Shares ETF | 8.71M | 2.66% | 762.45K |
| iShares Russell 2000 ETF | 7.03M | 2.10% | 3.44K |
| Vanguard Small Cap Index | 6.89M | 2.06% | 49.56K |
| Hood River Small-Cap Growth Instl | 5.10M | 1.53% | - |
| SPDR® S&P Biotech ETF | 4.76M | 1.42% | 6.15K |
| Vanguard Small Cap Value Index Inv | 4.45M | 1.33% | 13.91K |
| Macquarie Small Cap Core I | 4.02M | 1.21% | 114.39K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.55M | 1.06% | 5.33K |
| Delaware Small Cap Core I | 2.61M | 0.86% | 1.84M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 05, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | $55.20K |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | Buy | $9.74K |
| May 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | Buy | $42.25K |
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 3 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools